𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replication

✍ Scribed by Ban, Shintaro; Ueda, Youki; Ohashi, Masao; Matsuno, Kenji; Ikeda, Masanori; Kato, Nobuyuki; Miyachi, Hiroyuki

Book ID
122858901
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
690 KB
Volume
23
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thiazolidinediones inhibit hepatocarcino
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus–transgenic mice by peroxisome proliferator-activated receptor γ–independent regulation of nucleophosmin
✍ Andrea Galli; Elisabetta Ceni; Tommaso Mello; Simone Polvani; Mirko Tarocchi; Fr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 907 KB

Antidiabetic thiazolidinediones (TZD) have in vitro antiproliferative effect in epithelial cancers, including hepatocellular carcinoma (HCC). The effective anticancer properties and the underlying molecular mechanisms of these drugs in vivo remain unclear. In addition, the primary biological target

Hepatitis C virus core protein induces s
Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor α in transgenic mice: Implications for HCV-associated hepatocarcinogenesis
✍ Naoki Tanaka; Kyoji Moriya; Kendo Kiyosawa; Kazuhiko Koike; Toshifumi Aoyama 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 493 KB

## Abstract Persistent infection of hepatitis C virus (HCV) can lead to a high risk for hepatocellular carcinoma (HCC). HCV core protein plays important roles in HCV‐related hepatocarcinogenesis, because mice carrying the core protein exhibit multicentric HCCs without hepatic inflammation and fibro